Superior benefits of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors for diabetic kidney disease: A cohort study

Aim To compare cardiorenal outcomes of dipeptidyl peptidase‐4 inhibitors (DPP‐4is) and sodium‐glucose co‐transporter‐2 inhibitors (SGLT‐2is) in a national diabetic kidney disease (DKD) population. Methods A cohort study was conducted using Taiwan's National Health Insurance Research Database an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes, obesity & metabolism obesity & metabolism, 2025-01, Vol.27 (1), p.174-183
Hauptverfasser:	Chen, Hsiao‐Ling, Wang, I‐Ting, Tsai, Yi‐Wen, Lee, Yu‐Hsuan, Chen, Chen‐Huan, Chiang, Chern‐En, Cheng, Hao‐Min
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antidiabetics cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - epidemiology Cardiovascular Diseases - etiology Cardiovascular Diseases - prevention & control Cerebral infarction Cohort analysis Cohort Studies Congestive heart failure database research Diabetes Diabetes mellitus Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Diabetic Nephropathies - drug therapy Dipeptidyl-Peptidase IV Inhibitors - therapeutic use Epidermal growth factor receptors Female Glomerular filtration rate Glomerular Filtration Rate - drug effects Glucose transporter Heart failure Humans Kidney diseases Male Middle Aged Myocardial infarction pharmaco‐epidemiology Population studies real‐world evidence Renal failure Sodium-Glucose Transporter 2 Inhibitors - therapeutic use Taiwan - epidemiology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!